Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials

BACKGROUND: Advanced stage/recurrent clear cell ovarian cancers (CCOCs) are characterized by a low response to chemotherapy and a poor prognosis. There is growing interest in investigating novel/molecular targeted therapies in patients with CCOC in histotype-specific trials. However, CCOCs are not a...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedlander, Michael L., Russell, Kenneth, Millis, Sherri, Gatalica, Zoran, Bender, Ryan, Voss, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Ovarian Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841290/
https://www.ncbi.nlm.nih.gov/pubmed/26937756
http://dx.doi.org/10.1097/IGC.0000000000000677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841290/
https://www.ncbi.nlm.nih.gov/pubmed/26937756
http://dx.doi.org/10.1097/IGC.0000000000000677

Ejemplares similares